Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
about
The future of primary intraocular lymphoma (retinal lymphoma).Molecular pathology of primary intraocular lymphoma.Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics.Anaplastic large cell lymphoma involving anterior segment of the eye.Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Intraocular lymphoma: update on diagnosis and management.Primary testicular and intraocular lymphomas: two case reports and a review of the literatureIntra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.Recurrent pseudohypopyon in association with primary vitreoretinal lymphoma: a case report.Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature.Intravitreal injection of methotrexate in an experimental rabbit model: determination of ultrastructural changesEfficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal LymphomaDiagnosis and management of primary intraocular lymphoma: an updateClinical review: treatment of vitreoretinal lymphoma.Treatment approaches for primary CNS lymphomas.Chemotherapy in newly diagnosed primary central nervous system lymphoma.Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how?Primary Vitreoretinal Lymphoma: Management of Isolated Ocular Disease.Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.Intravitreal methotrexate for the treatment of choroidal neovascularization in multifocal choroiditisInvestigation of kinetics of methotrexate for therapeutic treatment of intraocular lymphoma.Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.Intravitreal methotrexate as adjunctive, palliative therapy in intraocular T-cell lymphoma.Intraocular lymphoma.
P2860
Q33950795-9A9C4E62-232B-4B24-B212-8F9F28153CA1Q34331092-252A92E4-7DE2-4FFC-BF17-201BCD0DD632Q35060364-823E1EAC-858E-4AA4-A2C8-343D10CDD7B9Q35088002-C40AE6DF-C30E-4BDE-855C-E644C3842EF0Q35152397-411043E6-669B-4CB8-83FD-89D8DD3DA396Q35599811-14CF98A0-181C-4E5D-937B-2E64E527DC5DQ35892007-967C7C26-E80E-475E-A0BC-571AC1E44574Q35908537-80DD0872-3DC1-4C4F-B4B3-ED975D29715CQ36048817-4AD1ED1D-6036-4A7E-829F-D97F8A47AFB4Q36071545-E9F05E73-CCA6-48AF-88BE-A9A930245EECQ36775495-C912BA00-5A91-4060-9ED9-726DB31CAF89Q37137224-770AD7A6-4192-499A-8221-F66A90590A2FQ37149388-315C9905-22CB-4147-BEB7-58E088CCAA8DQ37577405-D113586C-4E3D-4036-9B09-5C3079ABAF23Q37615331-0FF20B82-07E6-40A6-A35E-9DD163B6A013Q37739428-0425B19B-E422-46CE-97BB-747577C5A96CQ37905596-0ED93F8F-1887-4ADD-9651-7A0BC6169726Q38194808-864B953A-966C-4F89-A038-8F96F5AC4EA0Q38842910-9C03D80C-82EE-4704-856A-83DF949D170AQ41037004-EA0B4341-9501-4504-BC32-C3415AD7ECE1Q42574300-9EDF26A9-8F9A-41E4-9D23-5D73C71B6976Q42852900-E95716CA-2C42-4907-9E2F-1C4BFC9B3807Q48547141-DFE2A970-CA3B-43CA-A9A4-565640008532Q50913370-684BFF68-73F4-446C-9E7B-CE287F793934Q50913374-1D129610-B4BD-4A77-80C5-E561E0C67F2CQ51565100-55BA2D54-0EBF-4694-9394-B5401DBD7A62Q55312500-ACCB0567-7ED7-4382-B9DD-FF0D05EE17E4
P2860
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@ast
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@en
type
label
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@ast
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@en
prefLabel
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@ast
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@en
P2093
P2860
P356
P1476
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
@en
P2093
P2860
P304
P356
10.1136/BJO.83.4.448
P407
P577
1999-04-01T00:00:00Z